Valuation: Biogen Inc.

Market Cap 36.06B 32.13B 29.39B 26.77B 50.45B 3,408B 51.81B 353B 141B 1,805B 135B 132B 5,694B P/E 2026 *
45.6x
P/E 2027 * 21.9x
Enterprise Value 41.69B 37.15B 33.98B 30.95B 58.34B 3,940B 59.91B 408B 163B 2,087B 156B 153B 6,584B EV / Sales 2026 *
3.96x
EV / Sales 2027 * 3.64x
Free-Float
85.81%
Yield 2026 *
-
Yield 2027 * -
1 day-4.14%
1 week-0.05%
Current month-3.82%
1 month+10.94%
3 months+17.02%
6 months+30.30%
Current year+38.60%
1 week 243.65
Extreme 243.65
258.73
1 month 215.73
Extreme 215.73
258.78
Current year 160.36
Extreme 160.3645
258.78
1 year 151.83
Extreme 151.83
258.78
3 years 110.04
Extreme 110.035
268.3
5 years 110.04
Extreme 110.035
319.76
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
02/10/26 Exercice

Controller/Auditor

62 0.0000%
01/09/26 Free

General Counsel

7,405 0.0050%
04/08/26 Sell

Director

-593 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-4.14%-0.05%+63.35%-2.23% 37.61B
-3.76%+5.93%+50.49%+140.35% 1,263B
-1.45%+0.47%+45.73%+79.94% 665B
-2.24%+0.79%+33.51%+103.82% 521B
-1.06%-1.78%+48.37%+65.10% 387B
-2.27%+4.26%+75.22%+42.14% 371B
-0.10%+3.79%+32.16%+60.93% 310B
+0.13%+10.01%+12.08%+36.73% 293B
-3.80%+1.87%+55.13%+70.56% 259B
-3.96%+5.26%+36.24%+105.38% 216B
Average -1.53%+5.46%+45.23%+70.27% 432.3B
Weighted average by Cap. -0.68%+5.94%+45.40%+91.60%

Financials

2026 *2027 *
Net sales 10.53B 9.38B 8.58B 7.82B 14.73B 995B 15.13B 103B 41.23B 527B 39.52B 38.67B 1,663B 10.76B 9.59B 8.77B 7.99B 15.06B 1,017B 15.47B 105B 42.14B 539B 40.4B 39.53B 1,700B
Net income 788M 702M 642M 585M 1.1B 74.47B 1.13B 7.72B 3.09B 39.44B 2.96B 2.89B 124B 1.79B 1.59B 1.46B 1.33B 2.5B 169B 2.57B 17.49B 7B 89.41B 6.71B 6.56B 282B
Net Debt 5.63B 5.02B 4.59B 4.18B 7.88B 532B 8.1B 55.17B 22.06B 282B 21.15B 20.69B 890B 3.08B 2.75B 2.51B 2.29B 4.31B 291B 4.43B 30.17B 12.06B 154B 11.56B 11.32B 487B
Projected Income Statement - Annual - Biogen Inc.
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
05/11/26 $244.01 -4.11% 1,178,771
04/11/26 $254.46 +2.22% 1,348,003
03/11/26 $248.93 -0.03% 1,057,628
02/11/26 $249.01 -1.82% 1,172,994
30/10/26 $253.62 +1.59% 1,303,306
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Biogen Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
36
Last Close Price
244.01USD
Average target price
264.82USD
Spread / Average Target
+8.53%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Biogen Inc.
  1. Stock Market
  2. Stocks
  3. BIIB Stock